A study on Immunity boosters for COVID-19
Not Applicable
- Registration Number
- CTRI/2021/04/032613
- Lead Sponsor
- D Sreedhar
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Health science and Non-health science professionals
Exclusion Criteria
Pediatric and Geriatric Population
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The outcomes to be measured include preference of health science and non-health science professionals in immunity booster before and after the outbreak of COVID-19, perceived level of protection after taking the immunity boosters, awareness about the mechanism, side effects and medically advised dose of the supplements and role of immunity boosters in treatment and prevention of COVID-19Timepoint: 4 WEEKS
- Secondary Outcome Measures
Name Time Method ilTimepoint: NA